Experience

Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $2.8 billion aggregate principal amount of senior notes in three series, consisting of $800 million…

Davis Polk advised the underwriters in connection with the offering of C$950 million aggregate principal amount of 2.65% bonds due February 5, 2025, issued by the Province of Ontario. The…

Davis Polk advised the underwriters in connection with the offering of $2.5 billion aggregate principal amount of 3.050% bonds due January 29, 2024, issued by the Province of Ontario…

Davis Polk advised the underwriters in connection with the offering of $3 billion aggregate principal amount of 2.625% U.S. dollar bonds due January 25, 2022, issued by Her Majesty in…

Davis Polk is advising GE on the modification of terms of its merger agreement with Wabtec Corporation. Under the terms of the modified arrangements, GE will complete the spinoff of a…

Davis Polk advised Marsh & McLennan Companies, Inc. in connection with its SEC-registered offering of $5 billion aggregate principal amount of its $700 million aggregate principal…

Davis Polk advised an ad hoc group of holders of 7.785% senior notes due 2017, 9.50% senior notes due 2018 and 9.875% senior notes due 2020, in connection with the successful chapter 11…

Davis Polk advised an ad hoc group of secured lenders in connection with the successful chapter 11 restructuring of Dixie Electric, LLC and certain of its affiliates (the “Company”). On…

Davis Polk is advising Nutrisystem, Inc. on its $1.4 billion acquisition by Tivity Health, Inc. The transaction, which is expected to close in the first quarter of 2019, is subject to…

Davis Polk is advising Novo Nordisk on its $145 million acquisition of the U.S. and Canadian rights to Macrilen from Strongbridge Biopharma Plc. Novo Nordisk will also acquire newly issued…